Testa, Francesco
Melillo, Paolo
Di Iorio, Valentina
Iovino, Claudio
Farinaro, Francesco
Karali, Marianthi
Banfi, Sandro
Rossi, Settimio
Della Corte, Michele
Simonelli, Francesca
Article History
Received: 15 June 2022
Accepted: 11 October 2022
First Online: 21 October 2022
Competing interests
: F.T., P.M., S.B., and M.D.C. have received funding from Novartis. S.R. has received funding from Novartis and Bayer. F.S. has received funding from Biogen, Novartis, MA Provider, AIM Group, Uvet, SIFI, Bayer, Santhera Pharmaceuticals, Alia Therapeutics, Allergan, and 3P Solution. The other authors declare no conflict of interest.